BioMarin Pharmaceutical | BMRN - 普通股股本

金融业

USD

USD 7.59B

现金及等价物

USD 1.31B

USD 161.56M

USD 3.95B

USD 759.03M

USD 604.24M

USD 198.39M

USD -24.17M

3.04K

EPS每股收益

USD 0.46

股本和储备

USD 6.09B

USD 713.01M

债务利息支出

USD 2.78M

USD 17.85M

USD 597.18M

USD 10.58B

USD -46.57M

USD 676.18M

USD 198.39M

普通股股本

USD 192.3M

19.24

USD -26.32M

USD 875M

销售和管理费用

USD 322.21M

USD 1.3B

贸易债权人

USD 759.03M

应收帐款人

USD 908.21M

	普通股股本	更改		日
Acadia Pharmaceuticals	USD 169.18M		470K	2025-12
Agios Pharmaceuticals	USD 58.45M		169K	2025-12
Alnylam Pharmaceuticals	USD 132.38M		585K	2025-12
Amgen	USD 539M		1000K	2025-12
Bayer	EUR 982.42M		0	2025-12
Biogen	USD 146.7M		200K	2025-09
BioMarin Pharmaceutical	USD 192.3M		201K	2025-12
Gilead Sciences	USD 1.24B		1000K	2025-12
Incyte	USD 198.46M		2.33M	2025-12
Insmed	USD 214.26M		1.67M	2025-12
Ionis Pharmaceuticals	USD 161.97M		836K	2025-12
Moderna	USD 391M		2M	2025-09
Neurocrine Biosciences	USD 100.1M		400K	2025-12
PTC Therapeutics	USD 81.47M		1.54M	2025-12
Puma Biotechnology	USD 5K		0	2024-06
Regeneron Pharmaceuticals	USD 105.3M		1.1M	2025-09
Roche Holding	CHF 795.62M		699.54K	2025-12
Sarepta Therapeutics	USD 104.96M		196K	2025-12
Ultragenyx Pharmaceutical	USD 96.44M		88K	2025-09
United Therapeutics	USD 43.64M		740K	2025-12
Vertex Pharmaceuticals	USD 254M		0	2025-12